...
首页> 外文期刊>Breast cancer >Indications for Stereotactically-Guided Vacuum-Assisted Breast Biopsy for Patients with Category 3 Microcalcifications
【24h】

Indications for Stereotactically-Guided Vacuum-Assisted Breast Biopsy for Patients with Category 3 Microcalcifications

机译:立体定向引导的真空辅助乳腺活检对3类微钙化患者的适应症

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Since microcalcifications classified as category 3 on mammography include not only malignant lesions but also benign lesions, it is difficult to decide whether stereotactic vacuum-assisted breast biopsy (Mammotome®, MMT) should be performed or the patient should merely be follows. The purpose of this study is to adequately diagnose microcalcifications classified as category 3 and to formulate a correct clinical policy. In addition, we examined the characteristics of the calcifications.Methods: This study included 51 patients who underwent MMT from July 2003 to October 2004. All the cases were evaluated as category 3, and no abnormal findings were detected on ultrasonography. We classified the pattern of calcifications based on three aspects: 1. density and size, 2. pleomorphic appearance 3. number of calcifications per square centimeter.Results: Of the 51 patients, 14 were histologically diagnosed with ductal carcinoma in situ (DCIS). Heterogeneity in the density and size were observed in 9 of 14 patients (64.3%). The calcifications had a pleomorphic appearance in 6 of 14 patients (42.9%). A large number of calcifications (20/cm²) were observed in 8 of 14 patients (57.1%). Better examination characteristics were obtained with heterogeneity in density and size (AUC=0.72 95%C.I: 0.56-0.89) compared with pleomorphic appearance and the number of calcifications per square centimeter. The potential for malignancy was an average of 6 times higher for calcifications with heterogeneity in density and size compared to that for calcifications which were homogeneous in these aspects.Conclusion: Attention should be paid to prevent unnecessary mammotome procedures. Heterogeneity in the density and size of calcifications is a reliable criterion for clinical decision-making.
机译:背景:由于在乳腺钼靶上被分类为第3类的微钙化不仅包括恶性病变,还包括良性病变,因此很难决定是否应该进行立体定向真空辅助乳房穿刺活检(Mammotome®,MMT)或仅应跟随患者。这项研究的目的是充分诊断归类为第3类的微钙化并制定正确的临床策略。方法:本研究包括2003年7月至2004年10月接受MMT的51例患者。所有病例均被评估为3类,超声检查未发现异常。我们根据三个方面对钙化模式进行分类:1.密度和大小,2.多形性外观3.每平方厘米的钙化数目。结果:51例患者中,有14例经组织学诊断为原位导管癌。在14位患者中有9位(64.3%)观察到密度和大小的异质性。 14位患者中有6位(42.9%)出现钙化。 14名患者中有8名(57.1%)观察到大量钙化(20 /cm²)。与多晶形外观和每平方厘米的钙化数目相比,密度和尺寸上的异质性(AUC = 0.72 95%C.I:0.56-0.89)获得了更好的检查特性。在密度和大小上不均一的钙化相比于在这些方面均一的钙化,其潜在的恶性肿瘤平均高出六倍。结论:应注意预防不必要的Mammotome手术。钙化密度和大小的异质性是临床决策的可靠标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号